These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37500754)
21. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
22. Structuring of Organic Solvents at Solid Interfaces and Ramifications for Antimalarial Adsorption on β-Hematin Crystals. Olafson KN; Clark RJ; Vekilov PG; Palmer JC; Rimer JD ACS Appl Mater Interfaces; 2018 Sep; 10(35):29288-29298. PubMed ID: 30089201 [TBL] [Abstract][Full Text] [Related]
23. The Kinetics of β-Hematin Crystallization Measured by Depolarized Light Scattering. Rifaie-Graham O; Hua X; Bruns N; Balog S Small; 2018 Nov; 14(46):e1802295. PubMed ID: 30176111 [TBL] [Abstract][Full Text] [Related]
24. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779 [TBL] [Abstract][Full Text] [Related]
25. Mode of action of quinoline antimalarial drugs in red blood cells infected by Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055 [TBL] [Abstract][Full Text] [Related]
26. The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs. Quadros HC; Silva MCB; Moreira DRM Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056117 [No Abstract] [Full Text] [Related]
27. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Monti D; Vodopivec B; Basilico N; Olliaro P; Taramelli D Biochemistry; 1999 Jul; 38(28):8858-63. PubMed ID: 10413458 [TBL] [Abstract][Full Text] [Related]
28. Computational insights into the inhibition of β-haematin crystallization by antimalarial drugs. Delpe Acharige AMDS; Brennan MPC; Lauder K; McMahon F; Odebunmi AO; Durrant MC Dalton Trans; 2018 Nov; 47(43):15364-15381. PubMed ID: 30298161 [TBL] [Abstract][Full Text] [Related]
29. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization. Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414 [TBL] [Abstract][Full Text] [Related]
30. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin. Sonnet P; Mullié C Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Henry M; Alibert S; Rogier C; Barbe J; Pradines B Curr Top Med Chem; 2008; 8(7):563-78. PubMed ID: 18473883 [TBL] [Abstract][Full Text] [Related]